Rational Drug Design of Topically Administered Caspase 1 Inhibitors for the Treatment of Inflammatory Acne

被引:14
作者
Fournier, Jean-Francois [1 ]
Clary, Laurence [1 ]
Chambon, Sandrine [1 ]
Dumais, Laurence [1 ]
Harris, Craig Steven [1 ]
Millois, Corinne [1 ]
Pierre, Romain [1 ]
Talano, Sandrine [1 ]
Thoreau, Etienne [1 ]
Aubert, Jerome [1 ]
Aurelly, Michele [1 ]
Bouix-Peter, Claire [1 ]
Brethon, Anne [2 ]
Chantalat, Laurent [1 ]
Christin, Olivier [1 ]
Comino, Catherine [1 ]
El-Bazbouz, Ghizlane [1 ]
Ghilini, Anne-Laurence [1 ]
Isabet, Tatiana [3 ]
Lardy, Claude [2 ]
Luzy, Anne-Pascale [1 ]
Mathieu, Celine [1 ]
Mebrouk, Kenny [1 ]
Orfila, Danielle [1 ]
Pascau, Jonathan [1 ]
Reverse, Kevin [1 ]
Roche, Didier [2 ]
Rodeschini, Vincent [2 ]
Hennequin, Laurent Francois [1 ]
机构
[1] Nestle Skin Hlth R&D, 2400 Route Colles,BP 87, F-06902 Sophia Antipolis, France
[2] Edelris, 115 Ave Lacassagne, F-69003 Lyon, France
[3] LOrme Merisiers, Synchrotron Soleil, BP 48, F-91192 Gif Sur Yvette, France
关键词
INTERLEUKIN-1-BETA CONVERTING-ENZYME; MEDICINAL CHEMISTRY; IN-VIVO; SOLUBILITY; DISCOVERY; PREDICTION; SKIN; PERMEABILITY; DESCRIPTORS; PRINCIPLES;
D O I
10.1021/acs.jmedchem.8b00067
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The use of an interleukin beta antibody is currently being investigated in the clinic for the treatment of acne, a dermatological disorder affecting 650M persons globally. Inhibiting the protease responsible for the cleavage of inactive pro-IL1 beta into active IL-1 beta, caspase-1, could be an alternative small molecule approach. This report describes the discovery of uracil 20, a potent (38 nM in THP1 cells assay) caspase-1 inhibitor for the topical treatment of inflammatory acne. The uracil series was designed according to a published caspase-1 pharmacophore model involving a reactive warhead in P1 for covalent reversible inhibition and an aryl moiety in P4 for selectivity against the apoptotic caspases. Reversibility was assessed in an enzymatic dilution assay or by using different substrate concentrations. In addition to classical structure activity-relationship exploration, topical administration challenges such as phototoxicity, organic and aqueous solubility, chemical stability in solution, and skin metabolic stability are discussed and successfully resolved.
引用
收藏
页码:4030 / 4051
页数:22
相关论文
共 51 条
[11]   Benzhydryl as an efficient selective nitrogen protecting group for uracils [J].
Fan, W ;
Buhendwa, MG ;
Weaver, DF .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (26) :9307-9309
[12]   Intrinsic Property Forecast Index (iPFI) as a Rule of Thumb for Medicinal Chemists to Remove a Phototoxicity Liability [J].
Fournier, Jean-Francois ;
Bouix-Peter, Claire ;
Duvert, Denis ;
Luzy, Anne-Pascale ;
Ouvry, Gilles .
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (07) :3231-3236
[13]   MATHEMATICAL CONTRIBUTION TO STRUCTURE-ACTIVITY STUDIES [J].
FREE, SM ;
WILSON, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1964, 7 (04) :395-&
[14]   Fragment-based drug design: How big is too big? [J].
Hajduk, Philip J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :6972-6976
[15]   Establishment of an in silico phototoxicity prediction method by combining descriptors related to photo-absorption and photo-reaction [J].
Haranosono, Yu ;
Kurata, Masaaki ;
Sakaki, Hideyuki .
JOURNAL OF TOXICOLOGICAL SCIENCES, 2014, 39 (04) :655-664
[16]   Caspases as therapeutic targets [J].
Howley, B. ;
Fearnhead, H. O. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2008, 12 (5A) :1502-1516
[17]  
Jain N, 2001, J PHARM SCI, V90, P234, DOI 10.1002/1520-6017(200102)90:2<234::AID-JPS14>3.0.CO
[18]  
2-V
[19]   IL-1β Drives Inflammatory Responses to Propionibacterium acnes In Vitro and In Vivo [J].
Kistowska, Magdalena ;
Gehrke, Samuel ;
Jankovic, Dragana ;
Kerl, Katrin ;
Fettelschoss, Antonia ;
Feldmeyer, Laurence ;
Fenini, Gabriele ;
Kolios, Antonios ;
Navarini, Alexander ;
Ganceviciene, Ruta ;
Schauber, Juergen ;
Contassot, Emmanuel ;
French, Lars E. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 (03) :677-685
[20]  
Koo E. B., 2014, LANCET, V71, P450